Track market-moving stories before they get noisy

Private investors just put serious money behind a Hertz subsidiary most people have never heard of, and the bet is shaking up the entire rental and fleet sector this morning.

Outside investors are putting fresh money behind the fleet business Hertz Global Holdings (NASDAQ:HTZ) built from its own rental operations. Hertz stock is up 12% to $2.06 this morning after the company announced a strategic equity investment in its Oro Mobility subsidiary.

At the same time, Ryder System (NYSE:R | R Price Prediction) stock is up 2% to $240.01, a far smaller gain than the jump in Hertz shares. Avis Budget Group (NASDAQ:CAR) shares are up 0.9% to $103.34, trailing the gains in both Hertz stock and Ryder stock.

Transportation stocks as a group are stronger, as well. The iShares Transportation Average ETF (CBOE:IYT) is up 2% to $80.57. For broad-market context, the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 0.5% to $770.54, leaving Hertz stock as the clear outlier in the group.

Oro Mobility Lands Outside Backing
Hertz announced that Oro Mobility, its majority-owned fleet subsidiary, secured an $80 million strategic equity investment. Backers include Cohen Private Ventures and funds affiliated with Certares Opportunities and Knighthead Capital Management, a group putting private money into a unit Hertz built in-house. Because Oro Mobility is privately held and carries no ticker of its own, Hertz stock remains the main publicly traded link to the business.

Oro provides integrated driver-led and autonomous fleet management across mobility segments, and its driver-led unit supports rideshare platforms. Management at Hertz frames Oro as one piece of a platform covering rent-a-car, service, fleet and mobility.

Under the deal terms, Hertz keeps majority economic ownership of Oro and stays on as its fleet and corporate services partner. That structure leaves Hertz with the larger share of the economics while Oro’s new capital funds expansion across rideshare rentals, driver-led and autonomous vehicle fleet management.

Gil West, who serves as Hertz CEO and as executive chairman of Oro Mobility, tied the investment to the company’s broader transformation. West issued a statement. In it, he declared, “This investment underscores the strong foundation we’ve built at Oro and the immense opportunity ahead, validating both Oro’s trajectory and Hertz’s transformation strategy.” His comment frames Oro as evidence that the overhaul at Hertz is producing assets outside investors want to back.

A Rally Tied to Hertz Alone
Modest gains in Ryder stock, Avis shares and the transportation fund point to the Oro deal as the driver behind the surge in Hertz stock, while a broad sector rally would typically lift rental and fleet names more equally.

Business models explain part of that gap. Hertz and Avis shares both trade on travel demand, rental days and vehicle utilization, while Ryder stock moves with freight volumes and commercial fleet leasing, and such a split means the Oro deal carries limited direct read-through for Ryder’s leasing operations.

Meanwhile, customer bookings remain central to the Hertz story. The company carries its own exposure to travel demand, rental days and vehicle utilization, the same drivers that shape Avis. Hertz shares have also spent much of the year under heavy pressure, and sharp jumps in low-priced, volatile stocks have a habit of fading without follow-up news. However, outside backers chose to fund Oro on its own merits, which offers some balance against those rental risks.

Autonomous Partnerships Set the Next Test for Oro
Hertz now faces the question of whether Oro’s push into autonomous vehicle fleets turns into new partnerships. Oro’s new capital gives it the means to pursue those deals, and West has tied Oro’s progress to the Hertz overhaul.

Ryder and Avis shares are trading closer to the transportation fund, keeping the Oro story specific to Hertz. Given the volatility, investors should keep their Hertz stock holdings modest until partnership news supports the rally.

Contact [email protected] for any questions or corrections.

Enterprise technology provider IBM
IBM +1.72% 77

advanced to $238.95, up approximately 1.08%, at 11:52 a.m. ET on October 20 as investors weighed the release of llm-d 1.0. The open-source project aims to make running AI models at scale more efficient and reliable. For shareholders, the opportunity comes down to one thing: turning better infrastructure into paying customers.

According to IBM's announcement, the release helps multiple customers share computing resources and keeps services operating through planned upgrades. The project now draws on more than 500 contributors across over 25 organizations. That gives it technical reach. IBM's potential payoff lies in demand for supported Red Hat platforms and implementation services, but participation alone does not establish revenue.

The valuation snapshot puts shares 1.83% below the GF Value™ estimate of $243.40, suggesting a modest valuation cushion. The bigger test is execution. Paid deployments, stronger Red Hat growth and sustained software profitability would give investors something concrete to measure. A stronger AI platform opens doors. IBM still has to turn that access into profitable business.

Check the Warning Signs for

IBM

now!

Insatiable demand for artificial intelligence (AI) infrastructure has been a generational catalyst for memory specialist Micron Technology (MU +0.51%). After an extraordinary rally earlier this year, investors may be wondering where the stock is headed next.

Between 2020 and 2025, Micron stock generated an average gain of 28% during the calendar fourth quarter. So far this year, the story has looked different. After closing September at $1,065, Micron stock has fallen roughly 17% through Oct. 16.

Nevertheless, I see two upcoming catalysts that could help reverse sentiment and send Micron shares soaring before 2027 arrives.

Image source: Micron Technology.

Earnings season could ignite enthusiasm for memory stocks
Over the next several weeks, investors will hear from some of the world's largest AI companies. Space Exploration Technologies reports third-quarter earnings on Oct. 20, followed by Tesla and Meta Platforms on Oct. 21. Microsoft, Alphabet, Amazon, Apple, and Nvidia are also scheduled to report earnings throughout the remainder of October and November.

These earnings reports could be especially important for Micron because each of these companies is spending hundreds of billions of dollars building AI data centers, and they are increasingly discussing the same bottleneck: memory supply.

During SpaceX's second-quarter earnings call, Elon Musk said memory was the limiting factor for AI development. He implied that memory production was growing 20% annually while demand was increasing much faster, around 200%. His outlook was straightforward: "Economics 101 would suggest that the price increases."

Musk has also publicly praised Micron for being reasonable about memory prices, suggesting that the company's approach will strengthen customer relationships.

Meanwhile, Apple's former CEO Tim Cook touched on memory costs during the company's July earnings call. Cook characterized the situation as a "hundred-year flood," explaining why Apple decided to raise prices on certain products.

These comments are important because they illustrate how memory shortages aren't limited to data centers. Demand for high bandwidth memory (HBM) and advanced DRAM also affects consumer electronics, autonomous systems, and other end-markets.

As big tech companies continue discussing their capital expenditure (capex) plans, investors will likely receive additional evidence that memory supply remains tight. For Micron, that could reinforce expectations for higher average selling prices and stronger profitability heading into next year.

Micron's $35 billion stock buyback is another catalyst
On Oct. 8, Micron's board increased the company's share repurchase authorization to $35.16 billion. The timing of this announcement was particularly interesting. During Micron's most recent earnings call, CFO Mark Murphy explained that the company will increase capital returns beginning Dec. 9, subject to restrictions associated with CHIPS Act funding agreements.

When a company repurchases stock, it reduces the number of outstanding shares. That means future earnings are divided among fewer shares, potentially increasing earnings per share (EPS) even without additional profit growth.

Considering Micron is already witnessing record earnings momentum, stock buybacks should provide another tailwind. If the company begins repurchasing shares while its valuation remains depressed, the new authorization could prove especially lucrative for long-term investors.

MU Micron Technology$909.54+$4.64 (+0.51%)

NASDAQ · As of 1:48 PM ET 10/20/26

Should you buy Micron stock before 2027?
The most compelling part of Micron's investment thesis revolves around valuation. Wall Street's fiscal 2027 earnings estimates currently sit around $176 per share. With Micron trading around $911, that implies a forward price-to-earnings (P/E) ratio of roughly 5.2. That's a reasonable multiple for a company benefiting from one of the AI industry's biggest investment cycles.

Of course, there are reasons for investors to be cautious. Memory is notoriously cyclical. If manufacturers expand production too aggressively, prices could eventually decline. Moreover, rising competition from China's ChangXin Memory Technologies (CXMT) also presents a longer-term risk.

Nevertheless, Micron's near-term fundamentals are compelling. The company has secured numerous long-term strategic customer agreements that cover a substantial portion of its expected fiscal 2027 production, which provides greater visibility into future demand.

When combined with favorable industry conditions and Micron's expanded buyback authorization, the bull case becomes clear. Investors could see rising earnings, a shrinking share count, and potentially an expanding valuation multiple if confidence in the memory industry's outlook improves.

In turn, Micron stock could witness substantial stock-price appreciation sooner than most investors anticipate. In my view, Micron's recent sell-off presents an attractive entry point ahead of 2027. With shares trading at a reasonable valuation, I see Micron stock as a rock-solid buy for long-term investors.

Eli Lilly just posted 47.7% revenue growth and its weight-loss drugs are reshaping global healthcare, but whether that momentum turns a four-year investment into a windfall or a disappointment depends on factors most investors overlook.

Eli Lilly (NYSE:LLY | LLY Price Prediction) is one of the most closely followed growth stories in large-cap healthcare, so it makes sense to ask what a $1,000 investment could turn into by 2030. In intraday trading the shares were at $1,267.90, up 4.89% on the session from $1,208.74.

That $1,208.74 figure is the starting price the forecast model uses. The move came as healthcare stocks rallied across the sector. Lilly increased revenue 47.7% year over year last quarter, and that pace is a good reason to look further out.

What $1,000 Becomes at 10% a Year Start with the basic math. If Lilly compounds at a steady 10% a year, a $1,000 investment increased to $1,464.10 after four years, which brings you to around 2030. Over five years it hits $1,610.51. Treat both as example figures. They are not model forecasts.

The forecast model runs to a five-year horizon ending October 15, 2031, the modeled horizon closest to 2030. In its base case, a $1,000 investment would increase to about $1,830.10 by 2031, a total return of 83.01%. That figure rests on a per-share target of $2,212.06 and implies an annualized return of 12.85%, which beats the 10% hook.

Bull, Base and Bear Outcomes for Your $1,000 Scenario (2031 horizon) Target Share Price Total Return Value of $1,000 Bull $2,693 122.79% $2,227.90 Base $2,212.06 83.01% $1,830.10 Bear $1,456.52 20.5% $1,205 On the way to 2031, the base path places shares at $2,074.95 in October 2030. Measured from the model’s starting price, that would leave a $1,000 investment near $1,716.62. The bull and bear 2030 path points work out to $2,062.20 and $1,157.92. These 2030 numbers are example markers, not separate targets.

Over the next 12 months, the model’s base target is $1,478.22, an upside of 22.29%, with a bull case of $1,699.82 and a bear case of $1,245.07. Model confidence is 0.9 (high).

Wall Street’s consensus target is $1,330.14. Analyst ratings break down as 6 strong buy, 19 buy, 3 hold, 1 sell and 1 strong sell.

Three Drivers Powering Lilly’s Upside Case A Weight-Loss Franchise Still Expanding Mounjaro brought in $9.94 billion in the second quarter, up 91%. International sales rose 172% after the drug was added to China’s National Reimbursement Drug List. Zepbound added $4.93 billion, up 46%.

In the U.S. obesity market, about 6 out of 10 incretin prescriptions were for a Lilly medicine. A UBS analyst said on CNBC that “we think Lilly will dominate with 65% of that market over the next five or seven years.”

Earnings That Keep Beating Q2 EPS of $8.38 exceeded the $6.58 estimate, giving Lilly 5 consecutive beats. Management raised full-year 2026 revenue guidance to $85 billion to $87 billion, up from $82 billion to $85 billion.

A Pipeline Built for the Next Decade Lilly plans to file retatrutide in quarter one, 2027. The oral GLP-1 Foundayo is set for a global launch in 2027, and the company has more than 40 active phase three programs. CEO David A. Ricks said “Lilly’s future, after 150 years, has never been brighter.”

Risks That Could Shrink Your 2030 Payoff Pricing is the biggest pressure point. Realized prices fell 13% in Q2, while a 60% jump in volume did the heavy lifting. Acquired IPR&D charges of $2.78 billion in the quarter led management to lower the top of its EPS guidance to $36.50 from $37. Mounjaro and Zepbound make up the majority of revenue, so any slowdown in that franchise would hit the whole company.

Competition from Novo Nordisk (NYSE:NVO) and newer GLP-1 entrants could pressure market share. Possible pharmaceutical tariffs and manufacturing limits add more uncertainty.

Valuation is the final risk. At a trailing P/E of about 40, the stock leaves little room for disappointment. The bear case annualizes at just 3.8%, well below the 10% hook.

Where Your $1,000 Could Land by 2030 and Beyond At the modeled 2031 horizon, a $1,000 stake in Lilly ranges from $1,205 in the bear case to $2,227.90 in the bull case, with a base case of $1,830.10. The example 2030 markers run from $1,157.92 to $2,062.20.

Over the coming quarters, the retatrutide filing and the Foundayo launch are the milestones most likely to move these scenarios. All of these figures represent projections rather than certainty. Consider it a projection, not investment advice.

Contact [email protected] for any questions or corrections.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? PENN Entertainment (PENN - Free Report) , which belongs to the Zacks Gaming industry, could be a great candidate to consider.

This casino operator has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 72.86%.

For the last reported quarter, PENN Entertainment came out with earnings of $0.44 per share versus the Zacks Consensus Estimate of $0.35 per share, representing a surprise of 25.71%. For the previous quarter, the company was expected to post earnings of $0.05 per share and it actually produced earnings of $0.11 per share, delivering a surprise of 120.00%.

Price and EPS Surprise

Thanks in part to this history, there has been a favorable change in earnings estimates for PENN Entertainment lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

PENN Entertainment currently has an Earnings ESP of +2.62%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on November 5, 2026.

With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.

Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Xylem (XYL - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis water and wastewater treatment company is expected to post quarterly earnings of $1.47 per share in its upcoming report, which represents a year-over-year change of +7.3%.

Revenues are expected to be $2.28 billion, up 0.5% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.26% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Xylem?For Xylem, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.27%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that Xylem will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Xylem would post earnings of $1.34 per share when it actually produced earnings of $1.46, delivering a surprise of +8.96%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Xylem doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year increase in earnings on higher revenues when UMB Financial (UMBF - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis bank holding company is expected to post quarterly earnings of $3.22 per share in its upcoming report, which represents a year-over-year change of +19.3%.

Revenues are expected to be $749.94 million, up 9.2% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.33% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for UMB?For UMB, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.08%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination makes it difficult to conclusively predict that UMB will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that UMB would post earnings of $3.08 per share when it actually produced earnings of $3.57, delivering a surprise of +15.91%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

UMB doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Banks - Midwest industry, 1st Source (SRCE - Free Report) , is soon expected to post earnings of $1.83 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +7%. This quarter's revenue is expected to be $117.95 million, up 6.6% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for 1st Source has been revised 2.5% up to the current level. Nevertheless, the company now has an Earnings ESP of +0.55%, reflecting a higher Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that 1st Source will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects Invesco (IVZ - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis investment management company is expected to post quarterly earnings of $0.74 per share in its upcoming report, which represents a year-over-year change of +21.3%.

Revenues are expected to be $1.39 billion, up 17.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.82% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Invesco?For Invesco, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.19%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Invesco will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Invesco would post earnings of $0.67 per share when it actually produced earnings of $0.71, delivering a surprise of +5.97%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Invesco doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects HCA Healthcare (HCA - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis hospital operator is expected to post quarterly earnings of $6.75 per share in its upcoming report, which represents a year-over-year change of -3%.

Revenues are expected to be $19.38 billion, up 1.1% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.2% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for HCA?For HCA, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.73%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that HCA will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that HCA would post earnings of $7.57 per share when it actually produced earnings of $7.59, delivering a surprise of +0.26%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

HCA doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

IQVIA Holdings (IQV - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis clinical testing company is expected to post quarterly earnings of $3.24 per share in its upcoming report, which represents a year-over-year change of +8%.

Revenues are expected to be $4.36 billion, up 6.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for IQVIA?For IQVIA, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.09%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that IQVIA will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that IQVIA would post earnings of $3.02 per share when it actually produced earnings of $3.15, delivering a surprise of +4.30%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

IQVIA doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects ExlService Holdings (EXLS - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis provider of outsourcing services is expected to post quarterly earnings of $0.56 per share in its upcoming report, which represents a year-over-year change of +16.7%.

Revenues are expected to be $616.29 million, up 16.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for ExlService Holdings?For ExlService Holdings, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.06%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that ExlService Holdings will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that ExlService Holdings would post earnings of $0.55 per share when it actually produced earnings of $0.59, delivering a surprise of +7.27%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

ExlService Holdings appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAnother stock from the Zacks Computers - IT Services industry, Roper Technologies (ROP - Free Report) , is soon expected to post earnings of $5.79 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +12.7%. Revenues for the quarter are expected to be $2.18 billion, up 7.9% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Roper Technologies has remained unchanged. Nevertheless, the company now has an Earnings ESP of +1.13%, reflecting a higher Most Accurate Estimate.

When combined with a Zacks Rank of #2 (Buy), this Earnings ESP indicates that Roper Technologies will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Mirion Technologies, Inc. (MIR - Free Report) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.12 per share in its upcoming report, which represents no change from the year-ago quarter.

Revenues are expected to be $277.91 million, up 24.6% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.97% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Mirion Technologies?For Mirion Technologies, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.64%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Mirion Technologies will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Mirion Technologies would post earnings of $0.1 per share when it actually produced earnings of $0.12, delivering a surprise of +20.00%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Mirion Technologies doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAnother stock from the Zacks Technology Services industry, SLB (SLB - Free Report) , is soon expected to post earnings of $0.62 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -10.1%. Revenues for the quarter are expected to be $9.29 billion, up 4% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for SLB has been revised 2.7% down to the current level. Nevertheless, the company now has an Earnings ESP of -1.45%, reflecting a lower Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that SLB will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Evergy Inc (EVRG - Free Report) , which belongs to the Zacks Utility - Electric Power industry.

When looking at the last two reports, this electric utility has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 8.42%, on average, in the last two quarters.

For the most recent quarter, Evergy was expected to post earnings of $0.82 per share, but it reported $0.88 per share instead, representing a surprise of 7.32%. For the previous quarter, the consensus estimate was $0.63 per share, while it actually produced $0.69 per share, a surprise of 9.52%.

Price and EPS Surprise

Thanks in part to this history, there has been a favorable change in earnings estimates for Evergy lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Evergy has an Earnings ESP of +4.41% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on November 5, 2026.

Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.

Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Image: Shutterstock

Read MoreHide Full Article

Key Takeaways GlobalFoundries will build one new plant, with a second possible, under a U.S.-Japan investment initiative.Each facility could add 900,000 wafers in annual capacity, with operations at the 1st plant expected in 2029.GFS will invest $955 million in silicon photonics, silicon-germanium and advanced packaging.
GLOBALFOUNDRIES Inc. (GFS - Free Report) has been selected to operate two new semiconductor manufacturing facilities at its Malta, New York, campus under a U.S.-Japan investment initiative worth up to $21 billion. The expansion will increase the company’s U.S. production capacity and support demand for chips used in automotive, industrial, communications and data center applications.

Under the project, GlobalFoundries will use Japan’s initial investment of around $10 billion to build a new semiconductor manufacturing plant, which is expected to begin operations in 2029. An additional investment of approximately $10 billion could fund a second facility. Each plant is expected to add around 900,000 300mm wafers of annual production capacity. The project is expected to create approximately 27,000 construction and related jobs, along with more than 1,000 skilled manufacturing positions.

Separately, the company will reallocate $955 million from its existing U.S. government award to invest in silicon photonics, silicon-germanium and advanced packaging at its New York and Vermont facilities. These technologies are expected to support growing demand for artificial intelligence (AI), cloud data centers and high-speed communications.

The investment could strengthen GlobalFoundries’ position in the U.S. semiconductor market, support key customers such as Renesas, Apple, Cirrus Logic and General Motors, and enhance its role in the global semiconductor supply chain.

GlobalFoundries’ PeersUnited Microelectronics Corporation (UMC - Free Report) provides semiconductor foundry services for chips used in communications, automotive, consumer electronics and industrial applications. The company specializes in mature and specialty process technologies, including solutions for display drivers, power management and connectivity. UMC focuses on manufacturing reliability, process efficiency and long-term customer relationships to support demand for chips across a wide range of electronic devices.

Taiwan Semiconductor Manufacturing Company Limited (TSM - Free Report) manufactures advanced semiconductors for leading global technology companies, supporting applications such as AI, high-performance computing and mobile devices. Its advanced process technologies help produce powerful, energy-efficient chips for smartphones, AI accelerators and high-performance computing systems. TSMC provides advanced packaging technologies that help improve chip performance and meet the growing computing demands of next-generation applications.

Marvell Technology, Inc. (MRVL - Free Report) develops semiconductor solutions for data infrastructure, including AI systems, cloud computing and data centers. Its portfolio includes networking chips, optical connectivity solutions and custom silicon designed to support high-speed data transfer and efficient computing. As AI workloads increase the need for faster connectivity and greater data processing capacity, Marvell is focusing on technologies that help cloud providers and enterprise customers build scalable, high-performance infrastructure.

Published in artificial-intelligence semiconductor tech-stocks

Key Takeaways DXCM's G7 shows strong results in the CONNECT trial, supports CGM use in non-insulin-treated Type 2 diabetes.DXCM's G7 users achieve a 1.6% A1C reduction and spend five additional hours daily within the target range.Dexcom's CONNECT study shows 97% CGM use at 26 weeks, strengthening evidence for broader adoption.
DexCom, Inc. (DXCM - Free Report) recently announced that results from its CONNECT randomized controlled trial have been published in The New England Journal of Medicine. The study evaluated the benefits of its Dexcom G7 continuous glucose monitoring (CGM) system in adults with Type 2 diabetes who are not using insulin, adding to the clinical evidence supporting broader CGM adoption.

The findings are encouraging for DexCom, as stronger clinical evidence could help expand CGM adoption among people with Type 2 diabetes who are not on insulin. Wider physician acceptance and improved insurance coverage could create additional growth opportunities for the company. However, the extent to which the study translates into higher sales will depend on physician adoption, reimbursement support and patient uptake.

More on the NewsThe CONNECT study screened 440 participants across 22 primary care sites in the United States, with 283 eligible adults randomized to receive either Dexcom G7 or routine care over 26 weeks. Participants using the CGM system achieved an average A1C reduction of 1.6% from a baseline of 8.8%, representing a 0.9-percentage-point greater reduction than routine care. At 26 weeks, 68% of Dexcom G7 users achieved an A1C below 7.5%, while 46% reached below 7.0%.

The group also spent approximately five additional hours per day within the target glucose range of 70-180 mg/dL, with improvements emerging within the first week of use. Benefits were observed across several demographic and clinical characteristics, including age, diabetes duration and glucose-lowering treatments. Among participants using GLP-1 therapies, DexCom G7 delivered an additional 0.9-percentage-point A1C reduction compared with routine care. Notably, 97% of participants were still using CGM after 26 weeks, with most using it daily. The findings were first presented at the American Diabetes Association's 2026 Scientific Sessions and strengthen the clinical evidence supporting CGM use among adults with Type 2 diabetes who are not using insulin.

The publication is particularly relevant because it provides evidence supporting earlier CGM use in Type 2 diabetes management, potentially expanding the addressable market beyond patients who require insulin. The study's results may encourage more physicians to recommend continuous glucose monitoring and strengthen discussions around reimbursement and broader patient access. However, translating these findings into sustained revenue growth will depend on adoption rates, payer coverage and affordability. The study also adds to the clinical evidence supporting Dexcom's G7 platform, although longer-term data will be important in assessing the durability of the observed benefits.

Recent Development by DXCMRecently, DXCM released its 2026 “State of Type 2 Report: Global Access and Attitudes to Diabetes Technology” ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes. The report highlights significant gaps in CGM awareness and access while pointing to growing potential for combining CGM with GLP-1 therapies. Dexcom also partnered with Team Novo Nordisk, an all-diabetic professional cycling team primarily sponsored by Novo Nordisk, underscoring its focus on expanding CGM awareness and adoption.

DXCM’s Industry ProspectsAccording to Grand View Research, the global CGM devices market size was valued at $13.4 billion in 2025 and is projected to grow beyond $41.4 billion by 2033, at a CAGR of 15.1% from 2026 to 2033.

The primary driver of market growth is the rising global prevalence of diabetes, which has increased demand for more efficient, real-time glucose monitoring solutions.

Updates From DXCM PeersAbbott Laboratories (ABT - Free Report) recently reported new real-world evidence supporting the benefits of CGM technology, including its FreeStyle Libre systems, for adults with Type 2 diabetes using basal insulin. According to studies, CGM use was associated with a 45% lower risk of death at 12 months and a 36% lower risk at 24 months.

A separate French observational study involving more than 253,000 people with Type 2 diabetes found that Abbott's Libre technology was associated with lower hospitalization rates for acute diabetes-related events across different treatment groups. These findings strengthen the clinical evidence supporting CGM adoption and could help ABT expand the reach of its diabetes care portfolio.

Medtronic (MDT - Free Report) recently completed the exchange-offer process for its diabetes business, MiniMed Group and announced final results on Oct. 14, 2026. The offer was oversubscribed, and Medtronic exchanged its remaining 252.8 million MiniMed shares for approximately 55 million Medtronic ordinary shares. Following the transaction, Medtronic will no longer retain an ownership stake in MiniMed, which is expected to operate as an independent publicly traded company.

The separation marks a strategic shift for Medtronic, allowing it to focus more closely on its remaining medical technology businesses, while MiniMed will pursue growth in diabetes care as a standalone company. The development is relevant to the competitive landscape for diabetes devices, although its longer-term impact will depend on MiniMed's performance as an independent business.

Insulet (PODD - Free Report) announced enhancements to its Omnipod 5 automated insulin delivery system in June 2026, alongside expanded compatibility with Abbott's FreeStyle Libre 3 Plus sensor in the United States. The upgraded algorithm introduces a 100 mg/dL target glucose setting and improved alarm handling, aiming to improve time in range and help users spend more time in automated mode. The expanded sensor compatibility also gives users greater flexibility in choosing their diabetes management technology. Separately, Insulet reported second-quarter 2026 revenues of $801.7 million, up 23.5% year over year, with Omnipod revenue increasing 24.6%.

These developments highlight continued product innovation and commercial momentum, which could support Insulet's growth in automated insulin delivery. However, sustained performance will depend on continued adoption, international expansion and execution in an increasingly competitive diabetes technology market.

Key Takeaways Amkor's Computing revenues hit a Q2 record, rising 20% sequentially and 23% year over year on AI demand.Amkor targets four 2.5D and four HDFO product launches in 2026, alongside TSMC and NVIDIA partnerships.Amkor's gross margin rose to 16.8%, but $2.5B-$3B in 2026 capex and Arizona ramp risks may pressure margins.
Amkor Technology (AMKR - Free Report) is benefiting from accelerating AI and data center investments, driving demand for its advanced semiconductor packaging and test solutions. Computing revenues reached a quarterly record in the second quarter of 2026, increasing 20% sequentially and 23% year over year. Management projected nearly 30% sequential Computing revenue growth in the third quarter, supported by AI infrastructure demand and its high-density fan-out (HDFO) data center CPU ramp.

The opportunity extends beyond one program. Amkor has active engagements across 2.5D integration, HDFO and emerging co-packaged optics technologies. Management highlighted 11 customers across 2.5D programs and five HDFO customers with 10 active engagements, targeting four product launches in each category during 2026. Its 10-year advanced packaging agreement with TSMC and multi-year NVIDIA partnership strengthen technology collaboration and long-term growth opportunities.

Improving manufacturing efficiency provides another advantage. Gross margin expanded to 16.8% from 12% a year earlier, supported by higher factory utilization. Meanwhile, manufacturing expansions in Arizona and Korea should strengthen its ability to support future AI and high-performance computing demand.

However, substantial capital requirements, semiconductor cyclicality and manufacturing execution risks remain challenges. Amkor expects 2026 capital expenditures of $2.5 billion to $3 billion, while underutilized Arizona capacity could pressure margins during its initial ramp.

Accelerating AI demand, expanding customer programs and strategic partnerships position Amkor to sustain advanced packaging growth, but successful capacity ramps and consistent utilization will be essential to sustaining momentum.

How Are AMKR’s Advanced Packaging Rivals Positioned?Intel Corporation (INTC - Free Report) competes in advanced AI packaging through its Foundry business, offering EMIB silicon bridges, Foveros 3D stacking and EMIB-T technology. Intel operates advanced packaging facilities in New Mexico, supporting high-density chiplet integration for demanding data center workloads. By combining semiconductor fabrication with advanced assembly and testing capabilities, Intel offers an integrated manufacturing alternative that could challenge Amkor's position in complex AI packaging.

GlobalFoundries (GFS - Free Report) is expanding its presence in the advanced packaging ecosystem through silicon interposer manufacturing. In October 2026, GlobalFoundries announced a five-year, $2 billion agreement with TSMC to manufacture silicon interposers for its CoWoS advanced packaging ecosystem. With production expected to ramp in the first half of 2028, GlobalFoundries could strengthen competition for advanced packaging opportunities, although its interposer manufacturing role differs from Amkor's assembly-and-test services.

AMKR’s Share Price Performance, Valuation & EstimatesAMKR’s shares are up 6.5% year to date, underperforming the broader Zacks Computer and Technology sector’s 15.8% growth.

AMKR’s YTD Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, AMKR trades at a forward 12-month P/E of 15.56X, higher than the industry average of 11.36X. The company carries a Value Score of A.

AMKR’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for 2026 earnings is pegged at $2.60 per share, unchanged over the past 30 days, implying 73.3% year-over-year growth.

Image Source: Zacks Investment Research

AMKR stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

-

Leading institutions will evaluate StarGuide GXi across quantitative imaging, dynamic imaging and emerging theranostic applications Clinical experience from more than 1,000 patient studies was established ahead of the European Association of Nuclear Medicine (EANM) 2026 Annual Meeting in Vienna, Austria Insights will help guide the future evolution of GE HealthCare's digital SPECT/CT platform and inform the next generation of nuclear medicine imaging CHICAGO & VIENNA--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and Rambam Health Care Campus.

Across the program, participating institutions will evaluate image quality, quantitative performance, dynamic imaging and workflow while providing clinical and research feedback to help inform the future evolution of StarGuide GX.

“Nuclear medicine is entering a new era in which imaging is expected to do more than identify disease – it is increasingly being used to quantify biological processes, support treatment decisions and monitor response to therapy,” said Erez Levy, Executive Director, Molecular Imaging, GE HealthCare. “By working across multiple regions and care environments, we aim to generate clinical and research insights that can help inform innovation as imaging, quantitation and workflow needs evolve.”

Expanding quantitative and dynamic imaging capabilities

StarGuide GX uses dual-sided cadmium zinc telluride (dsCZT) detector technology and is designed to support high-sensitivity, high-resolution imaging, quantitative imaging and dynamic acquisitions. Its detector configuration allows the detectors to move close to the patient during imaging, while its patented dual-collimator detector design is intended to eliminate the need for manual external collimator exchanges and streamline imaging workflows.

Additionally, the system is engineered to support radionuclides across a broad energy range and, in research settings, it may also be evaluated for imaging radionuclides associated with emerging alpha-emitter research, including Actinium-225, focused on the potential to expand theranostic applications.ii

“The technological innovations introduced by StarGuide GX are particularly exciting for the future of theranostics,” shared Prof. Frederic Courbon, Head of the Imaging Department, Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse. “The system's ergonomic design and flexibility have the potential to significantly improve workflow while supporting precision in quantitative imaging and high-energy radionuclide applications. Our first experience suggests that StarGuide GX represents a meaningful step forward in enabling advanced theranostic practices.”

StarGuide GX also uses NVIDIA RTX™ accelerated computing to support image reconstruction, and includes a Low-Medium Energy collimator that is designed to provide up to 2.67-times system volume sensitivity.iii

Global collaborations advance nuclear medicine research

Five new, global clinical collaborations will evaluate the platform across diverse care settings:iv

Hadassah Medical Center (Israel): Evaluate advanced quantitative capabilities following the system’s recent field upgrade. Mayo Clinic (United States): Evaluate advanced quantitative and dynamic imaging applications. Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse (France): Assess StarGuide GX, the department's general-purpose SPECT/CT platform, across routine oncology imaging and clinical research. Peking University First Hospital (China): Explore novel tracer research and preclinical applications. Rambam Health Care Campus (Israel): Evaluate StarGuide GX imaging workflows through extensive clinical use across a broad range of nuclear medicine applications and tracers. These new collaborations build on GE HealthCare’s work with University Hospital Essen in Germany, which in June 2026 opened a new state-of-the-art Nuclear Medicine Center featuring the world’s first installation of StarGuide GX SPECT/CT.

To date, these diverse healthcare institutions have scanned more than 1,000 patients.

StarGuide GX received CE Mark in November 2025 and is available for sale in select European Union member states. The system is 510(k) pending with the U.S. FDA and is not currently available for sale in the United States.

For more information about GE HealthCare’s molecular imaging portfolio, visit gehealthcare.com or see the system in the company’s booth at the European Association of Nuclear Medicine’s 2026 Annual Meeting, October 17-21 in Vienna, Austria.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

StarGuide GX is CE marked and 510(k) pending with the U.S. FDA. Not available for sale in the United States. Investigational tracers. Not approved by the U.S. FDA or any other regulatory authority for clinical use. StarGuide GX with Low-Medium collimator has up to a 2.67-times increase in system volume sensitivity compared with NM/CT 870 DR with LEHRS collimator. System volume sensitivity measured per NEMA NU-1 2023, with adaptations for StarGuide GX. The products and applications evaluated may be investigational, may not be commercially available in all markets and may be subject to applicable regulatory requirements. Evaluation activities and timelines vary by institution. More News From GE HealthCare

Back to Newsroom

Asbury Automotive Group (ABG - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis auto dealership chain is expected to post quarterly earnings of $6.46 per share in its upcoming report, which represents a year-over-year change of -9.9%.

Revenues are expected to be $4.43 billion, down 7.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 6.08% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Asbury Automotive?For Asbury Automotive, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #5.

So, this combination makes it difficult to conclusively predict that Asbury Automotive will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Asbury Automotive would post earnings of $6.3 per share when it actually produced earnings of $6.82, delivering a surprise of +8.25%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Asbury Automotive doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Should You Invest in Asbury Automotive Group, Inc. (ABG)?

Before you invest in Asbury Automotive Group, Inc. (ABG), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)

Silver Prices Rebound Above $58 as BofA's $75 Outlook Faces a Solar Test BofA expects silver prices to recover in 2027, but manufacturers' efforts to use less of the metal leave investment demand carrying more of the burden. The silver price in US dollars rose 2.2% to $58.13 an ounce on Tuesday, recovering some ground after last week's inflation-driven losses.

Bank of America projects $75 for the second and third quarters of 2027, but its nearer-term forecast of $55 for the final quarter of 2026 allows for renewed weakness.

The bank's industrial assessment is cautious: "We expect a surplus in 2026, and further out, the fundamental outlook is less clear cut on a risk that silver substitution accelerates."

Solar expansion is no guarantee of silver demand BofA says: "The silver market has rebalanced on production discipline and demand from new applications including solar panels."

Its concern is how much metal each new installation requires: "Spending on solar panels has boosted silver demand, but a shift in technology likely reduces consumption by 11% in 2026."

That warning concerns solar-related consumption, rather than an 11% fall in total industrial demand.

Fraunhofer ISE's pilot work reduced silver use in a widely produced solar-cell design to roughly a tenth of typical levels, using copper for most electrical conduction.

"So-called nickel/copper electroplating could be firmly established in the photovoltaic market within two to three years," researcher Sven Kluska said in April.

The Silver Institute's annual outlook also warned: "Industrial demand is projected to decline by 3 percent, chiefly due to a further and marked slowdown in PV offtake."

That April assessment still anticipated a market deficit, unlike BofA's more recent surplus forecast.

A greater role for investment buying The sell-off following last week's US inflation figures showed how interest-rate expectations can overwhelm the industrial story.

Higher yields make interest-bearing assets more attractive relative to silver, which pays no income.

BofA sees scope for a change in what drives prices: "Silver could trade more like a precious metal".

It identifies returning investors and stronger Chinese imports as upside risks, with fund liquidation and additional supply on the downside.

Silver Price Forecast FAQ When does BofA expect silver at $75?

Its forecast is $75 an ounce for the second and third quarters of 2027, rather than an immediate target.

Why is solar demand a concern?

Manufacturers are reducing the amount of silver used in solar cells, potentially weakening demand even as installations increase.

Does BofA expect a silver shortage this year?

No. Its latest assessment anticipates a surplus in 2026 and identifies faster substitution as a risk further ahead.

Exchange Rates UK Research Our currency coverage draws on live market data, official economic releases and published bank research.

EUR/USD Forecast: Euro Rates Edge Higher as French Bond Risks Limit Recovery Scotiabank sees the Euro struggling to build momentum against the US Dollar as French bond tensions offset support from a weaker American currency. The Euro-to-Dollar exchange rate recovered to 1.1230 on Tuesday, up 0.15%, but remained below Friday's closing level.

Latest — Exchange Rates:

Euro to Dollar (EUR/USD): 1.122745 (+0.12%)

Pound to Dollar (GBP/USD): 1.337252 (+0.47%)

Dollar to Yen (USD/JPY): 158.20857 (-0.20%)

Scotiabank's assessment is neutral, with French borrowing concerns limiting the currency's ability to benefit from broader Dollar weakness.

Earlier, with EUR/USD at 1.1212, Scotiabank said: "The EUR is lagging its major currency peers on the day, weighed down by tensions in Eurozone government bond markets."

Scotiabank put the gap between French and German 10-year government bond yields near 150 basis points, equivalent to 1.5 percentage points, reflecting France's social and fiscal tensions.

That premium represents the extra yield investors demand to hold French debt rather than German bonds, making it a measure of concern about France's finances.

German improvement offers limited reassurance Germany's October ZEW survey showed a better assessment of current conditions, at minus 35.9, alongside a fall in expectations to 28.1.

ZEW president Achim Wambach said: "The German economy is slowly emerging from stagnation, but the recovery is not self-sustaining."

The institute identified high energy prices as a restraint on household spending and investment, through pressure on purchasing power and production costs.

Scotiabank also cautioned against treating the survey as a direct measure of economic activity: "The survey of financial professionals tends to be heavily weighted by market, rather than economic, developments but generally indicates the economy remains in "slow recovery" mode."

EUR/USD recovery needs stronger momentum Last week's rebound from support in the low 1.11s had raised hopes that an oversold Euro could stabilise.

Scotiabank now sees that opportunity struggling to develop:

"Sentiment and momentum are soft, preventing the EUR from taking advantage of the generally weaker USD tone and leveraging the bullish impulse that developed on the weekly chart last week-at least for now."

Scotiabank's support and resistance levels apply to intraday trading, rather than quarter-end forecasts.

"Intraday support is 1.1175/80. Resistance is 1.1275", Scotiabank says.

EUR/USD Exchange Rate FAQ Is Scotiabank bullish on EUR/USD?

Its latest short-term assessment is neutral, with weak momentum preventing last week's bullish signal from developing further.

Which EUR/USD levels is Scotiabank watching?

The bank identifies intraday support at 1.1175-1.1180 and resistance at 1.1275.

Exchange Rates UK Research Our currency coverage draws on live market data, official economic releases and published bank research.

The market expects Oneok Inc. (OKE - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis natural gas company is expected to post quarterly earnings of $1.46 per share in its upcoming report, which represents a year-over-year change of -2%.

Revenues are expected to be $11.77 billion, up 36.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.59% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Oneok?For Oneok, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.74%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that Oneok will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Oneok would post earnings of $1.39 per share when it actually produced earnings of $1.53, delivering a surprise of +10.07%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Oneok doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects Landstar System (LSTR - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis freight shipper and warehouser is expected to post quarterly earnings of $1.62 per share in its upcoming report, which represents a year-over-year change of +32.8%.

Revenues are expected to be $1.48 billion, up 22.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Landstar?For Landstar, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +4.84%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Landstar will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Landstar would post earnings of $1.42 per share when it actually produced earnings of $1.44, delivering a surprise of +1.41%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Landstar appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAmong the stocks in the Zacks Transportation - Truck industry, Marten Transport, Ltd. (MRTN - Free Report) , is soon expected to post earnings of $0.06 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +100%. This quarter's revenue is expected to be $231 million, up 4.8% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Marten Transport has been revised 9.1% down to the current level. Nevertheless, the company now has an Earnings ESP of 0.00%, reflecting an equal Most Accurate Estimate.

When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that Marten Transport will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects SoFi Technologies, Inc. (SOFI - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.17 per share in its upcoming report, which represents a year-over-year change of +54.6%.

Revenues are expected to be $1.26 billion, up 32.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.75% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for SoFi Technologies?For SoFi Technologies, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +2.42%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that SoFi Technologies will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that SoFi Technologies would post earnings of $0.11 per share when it actually produced earnings of $0.12, delivering a surprise of +9.09%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

SoFi Technologies appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAnother stock from the Zacks Financial - Miscellaneous Services industry, Rithm (RITM - Free Report) , is soon expected to post earnings of $0.5 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -7.4%. Revenues for the quarter are expected to be $1.49 billion, up 34.5% from the year-ago quarter.

The consensus EPS estimate for Rithm has been revised 0.5% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -1.34%.

This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Rithm will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects Simply Good Foods (SMPL - Free Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended August 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis nutritional foods company is expected to post quarterly earnings of $0.40 per share in its upcoming report, which represents a year-over-year change of -13%.

Revenues are expected to be $326.87 million, down 11.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.39% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Simply Good Foods?For Simply Good Foods, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.84%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that Simply Good Foods will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Simply Good Foods would post earnings of $0.35 per share when it actually produced earnings of $0.42, delivering a surprise of +20.00%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Simply Good Foods doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Key Takeaways MasTec sees fiber investment as its top long-term Communications growth driver for a possible 2027 recovery.MasTec is pursuing billions in hyperscaler projects, while Communications backlog rose to ~$5.46B in Q2 2026.Delays and softer wireless spending cut MasTec's 2026 Communications revenue outlook by ~$400M to $3.25B.
MasTec, Inc. (MTZ - Free Report) is positioning its Communications business for a potential recovery in 2027, supported by increasing investments in fiber infrastructure. Despite near-term project delays and softer wireless activity, management identifies fiber expansion as the segment's most significant long-term growth opportunity.

MasTec has been strategically shifting toward wireline infrastructure, reducing its historical dependence on wireless projects. The Communications segment delivered organic growth of more than 30% in 2025, reflecting the benefits of these investments. Increasing demand for high-capacity networks, driven by artificial intelligence (AI), cloud computing and data center interconnections, should further support this transition.

A major opportunity lies in hyperscaler connectivity projects. MasTec continues to secure work in this market and is pursuing billions of dollars in opportunities, including multiple projects exceeding $1 billion. Communications backlog reached approximately $5.46 billion in the second quarter of 2026, up from $5.01 billion a year earlier. Some newly booked work is expected to support revenues in 2027, although larger hyperscaler projects are unlikely to enter construction that year.

However, near-term challenges persist. Earlier-than-expected completion of Rural Digital Opportunity Fund projects, delayed wireline contract starts and deferred wireless spending ahead of new spectrum deployments prompted MasTec to reduce its 2026 Communications revenue outlook by approximately $400 million to $3.25 billion.

Looking ahead, the resumption of delayed projects and renewed customer spending could support a recovery in 2027. However, the timing of project execution and conversion of new opportunities into revenues will determine the pace of improvement.

Industry Peers Capitalize on Hyperscaler Infrastructure DemandMasTec's fiber expansion strategy aims to capitalize on rising hyperscaler connectivity demand and support a Communications recovery in 2027. Infrastructure peers Quanta Services, Inc. (PWR - Free Report) and EMCOR Group, Inc. (EME - Free Report) are similarly benefiting from accelerating data center investments and growing digital infrastructure requirements.

Quanta is expanding its hyperscaler infrastructure capabilities through integrated electrical, mechanical and grid interconnection solutions. Its technology and load center business benefits from increasing data center construction and power connectivity demand. In the second quarter of 2026, backlog reached a record $53 billion. Quanta’s strategic acquisitions, expanded fabrication capabilities and early customer engagement should support further growth opportunities.

EMCOR is capitalizing on strong data center demand within its network and communications market. In the second quarter of 2026, EME’s revenues from this market increased 45% within Electrical Construction and more than doubled within Mechanical Construction. Remaining performance obligations reached a record $17.14 billion, up 44% year over year. Expanding electrical capabilities and strategic acquisitions should support future growth.